4//SEC Filing
Grossi Federico 4
Accession 0001127602-22-022000
CIK 0001492422other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 4:22 PM ET
Size
4.4 KB
Accession
0001127602-22-022000
Insider Transaction Report
Form 4
Grossi Federico
See Remarks
Transactions
- Sale
Common Stock
2022-09-01$60.30/sh−2,500$150,750→ 104,884 total
Footnotes (1)
- [F1]This is a scheduled sale from 10b5-1 trading plan.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001720634
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 4:22 PM ET
- Size
- 4.4 KB